MTOR and systemic lupus erythematosus: This improvement is related to the fact that the accumulation of kynurenine (a tryptophan metabolite) and the depletion of cysteine and glutathione in SLE promote the activation of the mechanistic target to rapamycin (mTOR) inflammatory pathway [79].